<?xml version="1.0" ?>
<ns0:MeasureDoc xmlns:html="http://www.w3.org/1999/xhtml" xmlns:ns0="http://lc.ca.gov/legalservices/schemas/caml.1#" xmlns:ns3="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="1.0" xsi:schemaLocation="http://lc.ca.gov/legalservices/schemas/caml.1# xca.1.xsd">
	


	<ns0:Description>
		<ns0:Id>20250SB__054897AMD</ns0:Id>
		<ns0:VersionNum>97</ns0:VersionNum>
		<ns0:History>
			<ns0:Action>
				<ns0:ActionText>INTRODUCED</ns0:ActionText>
				<ns0:ActionDate>2025-02-20</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-03-24</ns0:ActionDate>
			</ns0:Action>
			<ns0:Action>
				<ns0:ActionText>AMENDED_SENATE</ns0:ActionText>
				<ns0:ActionDate>2025-05-05</ns0:ActionDate>
			</ns0:Action>
		</ns0:History>
		<ns0:LegislativeInfo>
			<ns0:SessionYear>2025</ns0:SessionYear>
			<ns0:SessionNum>0</ns0:SessionNum>
			<ns0:MeasureType>SB</ns0:MeasureType>
			<ns0:MeasureNum>548</ns0:MeasureNum>
			<ns0:MeasureState>AMD</ns0:MeasureState>
		</ns0:LegislativeInfo>
		<ns0:AuthorText authorType="LEAD_AUTHOR">Introduced by Senator Reyes</ns0:AuthorText>
		<ns0:Authors>
			<ns0:Legislator>
				<ns0:Contribution>LEAD_AUTHOR</ns0:Contribution>
				<ns0:House>SENATE</ns0:House>
				<ns0:Name>Reyes</ns0:Name>
			</ns0:Legislator>
		</ns0:Authors>
		<ns0:Title> An act to add Division 10.3 (commencing with Section 11720) to the Health and Safety Code, relating to public health.</ns0:Title>
		<ns0:RelatingClause>public health</ns0:RelatingClause>
		<ns0:GeneralSubject>
			<ns0:Subject>California Overdose Death and Addiction Reduction Act of 2025.</ns0:Subject>
		</ns0:GeneralSubject>
		<ns0:DigestText>
			<html:p>Existing law establishes the California Health and Human Services Agency, which includes departments charged with the administration of health, social, and other human services. Under existing law, the Legislature finds that state government has an affirmative role in alleviating problems related to the inappropriate use of alcoholic beverages and other drug use and that its major objective is protection of the public health and safety, particularly where problems related to inappropriate alcohol use and other drug use are likely to cause harm to individuals, families, and the community. The agency convened the Behavioral Health Task Force to inform its work on behavioral health issues across the state.</html:p>
			<html:p>This bill, the California Overdose
			 Death and Addiction Reduction Act of 2025, would require the California Health and Human Services Agency, on or before January 1, 2028, to direct the task force, or a successor group, to create a set of recommendations to support an implementation plan for reducing alcohol- and drug-related addiction deaths by 50% on or before 5 years from the date the task force provides the recommendations to the agency, but no later than January
			 1, 2033. The bill would authorize the task force to include additional members as deemed appropriate by the agency, including representatives from specified entities, experts, and providers, among others. The bill would require the agency to adopt the recommendations provided by the
			 task force and require the agency to consider specified information, including quality and performance measures to establish minimum standards for effective delivery of services.</html:p>
			<html:p>The bill would require the agency, on or before July 1, 2033, to provide the Governor and the Legislature a report of the findings and recommendations related to the extent that the 2033 goal was met and how effective the recommendations of the
			 task force were, and recommendations for beyond 2033 that will continue to reduce overdose deaths and addiction.</html:p>
			<html:p>The bill would also make related findings and declarations.</html:p>
		</ns0:DigestText>
		<ns0:DigestKey>
			<ns0:VoteRequired>MAJORITY</ns0:VoteRequired>
			<ns0:Appropriation>NO</ns0:Appropriation>
			<ns0:FiscalCommittee>YES</ns0:FiscalCommittee>
			<ns0:LocalProgram>NO</ns0:LocalProgram>
		</ns0:DigestKey>
		<ns0:MeasureIndicators>
			<ns0:ImmediateEffect>NO</ns0:ImmediateEffect>
			<ns0:ImmediateEffectFlags>
				<ns0:Urgency>NO</ns0:Urgency>
				<ns0:TaxLevy>NO</ns0:TaxLevy>
				<ns0:Election>NO</ns0:Election>
				<ns0:UsualCurrentExpenses>NO</ns0:UsualCurrentExpenses>
				<ns0:BudgetBill>NO</ns0:BudgetBill>
				<ns0:Prop25TrailerBill>NO</ns0:Prop25TrailerBill>
			</ns0:ImmediateEffectFlags>
		</ns0:MeasureIndicators>
	</ns0:Description>
	<ns0:Bill id="bill">
		<ns0:Preamble>The people of the State of California do enact as follows:</ns0:Preamble>
		<ns0:BillSection id="id_C534DC49-F905-4F44-A7DA-B62470A7C74B">
			<ns0:Num>SECTION 1.</ns0:Num>
			<ns0:Content>
				<html:p>This act shall be known, and may be cited as, the California Overdose Death and Addiction Reduction Act of 2025.</html:p>
			</ns0:Content>
		</ns0:BillSection>
		<ns0:BillSection id="id_BDEF39EA-EA5E-4478-BD40-9B1A0AAF71D8">
			<ns0:Num>SEC. 2.</ns0:Num>
			<ns0:Content>
				<html:p>
					(a)
					<html:span class="EnSpace"/>
					The Legislature makes the following findings and declarations:
				</html:p>
				<html:p>
					(1)
					<html:span class="EnSpace"/>
					In 2023, more than 11,000 Californians died because of fentanyl and other overdose deaths. California’s overdose death toll increased by 4 percent
				in 2023, while the number of deaths nationally declined for the first time in five years.
				</html:p>
				<html:p>
					(2)
					<html:span class="EnSpace"/>
					Excessive alcohol use resulted in an additional death toll of almost 20,000.
				</html:p>
				 
				<html:p>
					(3)
					<html:span class="EnSpace"/>
					Drug-related overdose deaths were the sixth leading acute cause of death with an age-adjusted death rate of 29.4 per 100,000 residents in 2023. The drug-related overdose age-adjusted death rate was greater than the age-adjusted death rates for chronic obstructive pulmonary disease, lung cancer, kidney diseases, and congestive heart failure.
				</html:p>
				<html:p>
					(4)
					<html:span class="EnSpace"/>
					New addiction medications and treatment strategies can dramatically reduce overdose deaths and reduce heavy drinking. Contingency management treatments strongly reduce stimulant use.
				</html:p>
				<html:p>
					(5)
					<html:span class="EnSpace"/>
					Almost 30,000,000 Californians are enrolled in health plans regulated by the Department of Managed Health Care and have coverage that includes treatment for substance use disorder.
				</html:p>
				<html:p>
					(6)
					<html:span class="EnSpace"/>
					Current measures for post-emergency department followup care report that only 28.6 percent of Medi-Cal members who visited an emergency department for an overdose or substance use disorder diagnosis received followup care after 30 days.
				</html:p>
				<html:p>
					(b)
					<html:span class="EnSpace"/>
					It is the intent of the Legislature that the state establish a goal of reducing alcohol- and drug-related addiction deaths by 50 percent by 2033 and that this goal continue in existence and be used to maintain and continue reductions of overdose death and addiction beyond
				2033.
				</html:p>
			</ns0:Content>
		</ns0:BillSection>
		<ns0:BillSection id="id_3A6D63C2-9B4D-48B0-856B-73AFD81BDD71">
			<ns0:Num>SEC. 3.</ns0:Num>
			<ns0:ActionLine action="IS_ADDED" ns3:href="urn:caml:codes:HSC:caml#xpointer(%2Fcaml%3ALawDoc%2Fcaml%3ACode%2Fcaml%3ALawHeading%5B%40type%3D'DIVISION'%20and%20caml%3ANum%3D'10.3.'%5D)" ns3:label="fractionType: LAW_SPREAD||commencingWith: 11720" ns3:type="locator">
				Division 10.3 (commencing with Section 11720) is added to the 
				<ns0:DocName>Health and Safety Code</ns0:DocName>
				, to read:
			</ns0:ActionLine>
			<ns0:Fragment>
				<ns0:LawHeading id="id_485388F4-04AA-4B15-8BBE-A95EED9C6229" type="DIVISION">
					<ns0:Num>10.3.</ns0:Num>
					<ns0:LawHeadingVersion id="id_51058B3B-C0DC-4370-A118-BDA7FB3A9719">
						<ns0:LawHeadingText>Overdose Death and Addiction Reduction</ns0:LawHeadingText>
					</ns0:LawHeadingVersion>
					<ns0:LawSection id="id_458C7AED-0E19-4431-A99C-9DDF80C1B416">
						<ns0:Num>11720.</ns0:Num>
						<ns0:LawSectionVersion id="id_5D264669-3E31-4BF8-9004-3718E9A09D84">
							<ns0:Content>
								<html:p>For purposes of this division, the following definitions apply:</html:p>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									“Agency” means the California Health and Human Services Agency, unless otherwise specified. 
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									“Task force” means the Behavioral Health Task Force convened by the agency or any successor group established by the agency to advise on behavioral health issues.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_3C5C5DD9-DF9A-4A01-A088-BA67D16D21E9">
						<ns0:Num>11721.</ns0:Num>
						<ns0:LawSectionVersion id="id_80FA58A1-C2FB-4F73-BDAD-AABCE033DD70">
							<ns0:Content>
								<html:p>On or before January 1, 2028, the California Health and Human Services Agency shall direct the Behavioral Health Task Force, or any successor group established by the agency to advise on behavioral health issues, to create a set of recommendations to support an implementation plan for reducing alcohol- and drug-related addiction deaths by 50 percent on or before five years from the date the task force provides the recommendations to the agency, but no later than January 1, 2033. The recommendations shall specify what can be accomplished pursuant to existing administrative authority and what will require additional regulations or legislation for implementation.</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_9029F479-CFB3-495A-9145-4F61164656C8">
						<ns0:Num>11722.</ns0:Num>
						<ns0:LawSectionVersion id="id_5D6D481E-3522-4009-A81E-D55C98AB4E38">
							<ns0:Content>
								<html:p>The task force, or a subcommittee established by the task force, may include additional members as deemed appropriate by the agency, including, but not limited to, representatives from other departments within the agency, the California Health Benefit Exchange, also known as Covered California, the Public Employees’ Retirement System, and the Behavioral Health Services Oversight and Accountability Commission. The task force may also include all of the following: </html:p>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									Representatives of consumer stakeholders that serve diverse populations.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									Substance use disorder treatment experts, researchers, and insurers.
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									Representatives from
						  clinics that provide primary care.
								</html:p>
								<html:p>
									(d)
									<html:span class="EnSpace"/>
									Primary care and substance use treatment providers.
								</html:p>
								<html:p>
									(e)
									<html:span class="EnSpace"/>
									Individuals with lived experiences in receiving substance use disorder treatment.
								</html:p>
								<html:p>
									(f)
									<html:span class="EnSpace"/>
									Representatives from different diverse groups, including those with different racial, cultural, ethnic, sexual orientation, gender, economic, linguistic, age, disability, and geographical backgrounds, so that the findings and recommendations reflect the communities of California.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_11AFF5F5-C29D-4CB8-8858-1111A492957E">
						<ns0:Num>11723.</ns0:Num>
						<ns0:LawSectionVersion id="id_05F5C69E-494C-47C9-BD75-8E017ED5A0AA">
							<ns0:Content>
								<html:p>In order to ensure the most accurate recommendations feasible, the task force shall evaluate the best available scientific, technological, medical, and socioeconomic information on overdose death and addiction to meet the 2033 goal.</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_939B3E97-D975-4F90-8FBC-7ED6B2772E1F">
						<ns0:Num>11724.</ns0:Num>
						<ns0:LawSectionVersion id="id_85B810AF-360A-4AB6-8EC4-7AE70942F58E">
							<ns0:Content>
								<html:p>The agency shall adopt the recommendations provided by the task force. In adopting recommendations to achieve the 2033 goal, the agency shall review and assess existing health coverage and health insurance treatment policies, practices, and data related to reducing addiction and deaths related to alcohol and drug use, including the applicability and adequacy of existing rules related to parity in coverage for treatment for substance use disorder. The agency shall also consider quality and performance measures to establish minimum standards for effective delivery of substance use disorder services, including all of the following:</html:p>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									Access to low barrier models of care for substance use disorders as defined by the federal Substance Abuse and Mental Health
						  Services Administration.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									Access to pharmacies that can provide addiction medication.
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									Access to primary care providers that can provide addiction medication and treatment.
								</html:p>
								<html:p>
									(d)
									<html:span class="EnSpace"/>
									Access to providers that are trained to provide and support models of care or evidence-based medication.
								</html:p>
								<html:p>
									(e)
									<html:span class="EnSpace"/>
									The interaction of comorbidities, such as mental illness or other behavioral health conditions.
								</html:p>
								<html:p>
									(f)
									<html:span class="EnSpace"/>
									Other characteristics in determining where disparate outcomes exist, including, but not limited to, race, ethnicity, gender, sexual orientation, language, age, income, and disability.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_C0E3426F-C060-4356-8A0E-8EAA750C089A">
						<ns0:Num>11725.</ns0:Num>
						<ns0:LawSectionVersion id="id_71739E08-08CE-48A0-869C-C0A19D7CAC71">
							<ns0:Content>
								<html:p>While implementing the goals of this division, the agency shall consult and consider the expertise of representatives from other state agencies that regulate, collect data, or contract with health plans or health insurers, including the State Department of Health Care Services, Covered California, Public Employees’ Retirement System, the Department of Health Care Access and Information, the State Department of Public Health, and the Emergency Medical Services Authority.</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
					<ns0:LawSection id="id_9FCE6E87-E66B-475E-8629-E93C4D69C1E7">
						<ns0:Num>11726.</ns0:Num>
						<ns0:LawSectionVersion id="id_4BABA7FD-1CAA-460F-84D0-BDF9D3DCD2F2">
							<ns0:Content>
								<html:p>
									(a)
									<html:span class="EnSpace"/>
									On or before July 1, 2033, the agency shall provide the Governor and the Legislature a report of findings and recommendations related to the extent to which the 2033 goal was met and how effective the recommendations of the task force were. This report shall also include recommendations for beyond 2033 that will continue to reduce overdose deaths and addiction. The report may include all of the following:
								</html:p>
								<html:p>
									(1)
									<html:span class="EnSpace"/>
									Quality measures, including, but not limited to, Healthcare Effectiveness Data and Information Set measures and the federal Centers for Medicare and Medicaid Services Child and Adult Core Set measures, the Quality Alignment Measure Set developed by the Public Employees’ Retirement System, as well as collaborative efforts with other
						  state agencies that purchase or negotiate health insurance coverage.
								</html:p>
								<html:p>
									(2)
									<html:span class="EnSpace"/>
									Surveys or other measures to assess consumer experience and satisfaction.
								</html:p>
								<html:p>
									(3)
									<html:span class="EnSpace"/>
									New measures and metrics that determine health outcomes.
								</html:p>
								<html:p>
									(4)
									<html:span class="EnSpace"/>
									Measures of social determinants of health that may contribute to substance use disorder treatment efficacy, such as housing security, food insecurity, caregiving, and other nonmedical determinants of health.
								</html:p>
								<html:p>
									(5)
									<html:span class="EnSpace"/>
									Other existing child and adult quality or outcome measures that the task force determines are appropriate.
								</html:p>
								<html:p>
									(b)
									<html:span class="EnSpace"/>
									The report shall also include the information considered under Section 11724 and the information and expertise from the entities listed in Section 11725.
								</html:p>
								<html:p>
									(c)
									<html:span class="EnSpace"/>
									The report to be submitted to the Legislature pursuant to subdivision (a) shall be submitted in compliance with Section 9795 of the Government Code.
								</html:p>
							</ns0:Content>
						</ns0:LawSectionVersion>
					</ns0:LawSection>
				</ns0:LawHeading>
			</ns0:Fragment>
		</ns0:BillSection>
	</ns0:Bill>
</ns0:MeasureDoc>